Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The PAI-1 mRNA-binding protein pseudogene (ENSG00000235756) is a segment of genomic DNA in humans that resembles the gene encoding a PAI-1 mRNA-binding protein but is classified as a *pseudogene*—meaning it is incapable of producing a functional protein product due to disabling mutations or the absence of necessary regulatory elements[1][2]. Pseudogenes may retain sequence similarity to related functional genes but typically have lost the ability to encode proteins. Some pseudogenes are transcribed into RNA and may influence gene expression through the production of noncoding RNAs, such as small interfering RNAs or by acting as molecular decoys for microRNAs, though direct evidence for this function is limited and context-specific[3][4][5]. There is no evidence that this pseudogene has therapeutic target potential or interacts with any known drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PAI-1 mRNA-binding protein pseudogene.